FBXO24
gene geneOn this page
Also known as FBX24
Summary
FBXO24 (F-box protein 24, HGNC:13595) is a protein-coding gene on chromosome 7q22.1, encoding F-box only protein 24 (O75426). Substrate recognition component of an SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex that mediates the ubiquitination and subsequent proteasomal degradation of target proteins.
This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of the ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbxs class. Multiple transcript variants encoding different isoforms have been found for this gene.
Source: NCBI Gene 26261 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 103 total
- MANE Select transcript:
NM_033506
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13595 |
| Approved symbol | FBXO24 |
| Name | F-box protein 24 |
| Location | 7q22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FBX24 |
| Ensembl gene | ENSG00000106336 |
| Ensembl biotype | protein_coding |
| OMIM | 609097 |
| Entrez | 26261 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 8 protein_coding, 1 retained_intron, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000241071, ENST00000427939, ENST00000461079, ENST00000465843, ENST00000466053, ENST00000468962, ENST00000474649, ENST00000488079, ENST00000498195, ENST00000883034, ENST00000883035
RefSeq mRNA: 3 — MANE Select: NM_033506
NM_001163499, NM_012172, NM_033506
CCDS: CCDS55138, CCDS5698, CCDS5699
Canonical transcript exons
ENST00000241071 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000710697 | 100592783 | 100593017 |
| ENSE00001955396 | 100586328 | 100586664 |
| ENSE00003545551 | 100594383 | 100594541 |
| ENSE00003553701 | 100600534 | 100601117 |
| ENSE00003567423 | 100595575 | 100595706 |
| ENSE00003597619 | 100589977 | 100590075 |
| ENSE00003634472 | 100591667 | 100591902 |
| ENSE00003634512 | 100600031 | 100600201 |
| ENSE00003690037 | 100595102 | 100595223 |
| ENSE00003790196 | 100590174 | 100590357 |
Expression profiles
Bgee: expression breadth ubiquitous, 172 present calls, max score 95.63.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1244 / max 64.9562, expressed in 21 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 80009 | 0.0813 | 18 |
| 80010 | 0.0431 | 5 |
Top tissues by expression
266 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 95.63 | gold quality |
| right testis | UBERON:0004534 | 95.44 | gold quality |
| testis | UBERON:0000473 | 92.64 | gold quality |
| sperm | CL:0000019 | 89.53 | gold quality |
| male germ cell | CL:0000015 | 87.57 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.57 | gold quality |
| adult organism | UBERON:0007023 | 84.46 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.15 | gold quality |
| sural nerve | UBERON:0015488 | 70.74 | gold quality |
| buccal mucosa cell | CL:0002336 | 69.63 | gold quality |
| granulocyte | CL:0000094 | 67.56 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 67.12 | gold quality |
| heart right ventricle | UBERON:0002080 | 67.05 | gold quality |
| stromal cell of endometrium | CL:0002255 | 67.03 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 66.89 | gold quality |
| metanephros cortex | UBERON:0010533 | 66.67 | gold quality |
| right uterine tube | UBERON:0001302 | 66.66 | gold quality |
| ectocervix | UBERON:0012249 | 66.51 | gold quality |
| endocervix | UBERON:0000458 | 66.31 | gold quality |
| right ovary | UBERON:0002118 | 66.05 | gold quality |
| left ovary | UBERON:0002119 | 66.04 | gold quality |
| body of uterus | UBERON:0009853 | 65.70 | gold quality |
| right lobe of liver | UBERON:0001114 | 64.74 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 64.26 | gold quality |
| blood | UBERON:0000178 | 64.10 | gold quality |
| secondary oocyte | CL:0000655 | 64.09 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 64.05 | gold quality |
| ovary | UBERON:0000992 | 63.99 | gold quality |
| myocardium | UBERON:0002349 | 63.79 | gold quality |
| vena cava | UBERON:0004087 | 63.79 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.20 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
8 targeting FBXO24, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3912-5P | 99.95 | 66.11 | 925 |
| HSA-MIR-4762-5P | 99.57 | 68.54 | 1424 |
| HSA-MIR-7151-5P | 99.37 | 67.82 | 613 |
| HSA-MIR-939-3P | 98.97 | 65.07 | 2347 |
| HSA-MIR-6884-3P | 98.05 | 65.32 | 750 |
| HSA-MIR-7113-5P | 97.88 | 67.33 | 1735 |
| HSA-MIR-4448 | 97.04 | 66.22 | 752 |
| HSA-MIR-6772-3P | 97.04 | 65.89 | 784 |
Literature-anchored findings (GeneRIF, showing 4)
- SCF-FBXO24 regulates cell proliferation by mediating ubiquitination and degradation of PRMT6. (PMID:32828318)
- FBXO24 Suppresses Breast Cancer Tumorigenesis by Targeting LSD1 for Ubiquitination. (PMID:37540490)
- FBXO24 modulates mRNA alternative splicing and MIWI degradation and is required for normal sperm formation and male fertility. (PMID:38470475)
- FOXK2 targeting by the SCF-E3 ligase subunit FBXO24 for ubiquitin mediated degradation modulates mitochondrial respiration. (PMID:38735474)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Fbxo24 | ENSMUSG00000089984 |
| rattus_norvegicus | Fbxo24 | ENSRNOG00000024922 |
Paralogs (1): MYCBP2 (ENSG00000005810)
Protein
Protein identifiers
F-box only protein 24 — O75426 (reviewed: O75426)
All UniProt accessions (5): O75426, A4D2D3, C9J4S8, C9K0U2, F8WC52
UniProt curated annotations — full annotation on UniProt →
Function. Substrate recognition component of an SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex that mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Specifically recognizes the deacetylated form of nucleoside diphosphate kinase A/NME1 and targets it for ubiquitin-mediated degradation. Functions as a key regulator of cell proliferation by targeting PRMT6 for ubiquitination and proteasomal degradation, leading to cell cycle inhibition. Also mediates ‘Lys-6’-linked polyubiquitination of the mitochondrial S-adenosylmethionine transporter SLC25A26, targeting it for degradation and thereby maintaining mitochondrial function during spermiogenesis. Promotes ubiquitination and degradation of mitochondrial aspartyl-tRNA synthetase DARS2, contributing to immunosuppressive activity. In the nucleus, targets FOXK2 for ubiquitin-mediated degradation, a process that critically modulates mitochondrial respiration and cellular bioenergetics in lung epithelial cells.
Subunit / interactions. Directly interacts with SKP1 and CUL1. Interacts with NME1. Interacts with PRMT6. Interacts with DARS2. Interacts with FOXK2. Interacts with RELA.
Subcellular location. Mitochondrion. Nucleus.
Induction. By bacterial infection.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| O75426-1 | 1 | yes |
| O75426-2 | 2 | |
| O75426-3 | 3 | |
| O75426-4 | 4 |
RefSeq proteins (3): NP_001156971, NP_036304, NP_277041* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000408 | Reg_chr_condens | Repeat |
| IPR001810 | F-box_dom | Domain |
| IPR009091 | RCC1/BLIP-II | Homologous_superfamily |
| IPR036047 | F-box-like_dom_sf | Homologous_superfamily |
| IPR052866 | F-box_protein_24 | Family |
Pfam: PF00415, PF12937
UniProt features (9 total): splice variant 5, chain 1, domain 1, repeat 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O75426-F1 | 77.36 | 0.33 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 145 (showing top):
TGGTGCT_MIR29A_MIR29B_MIR29C, GOBP_SINGLE_FERTILIZATION, AREB6_03, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GCAAGGA_MIR502, AREB6_01, AP4_Q6, TGACCTY_ERR1_Q2, GOBP_MALE_GAMETE_GENERATION, CAGCTG_AP4_Q5, CAGCAGG_MIR370, GOBP_CILIUM_ORGANIZATION, BACH2_01, TGIF_01, GOBP_RNA_SPLICING
GO Biological Process (11): mRNA splicing, via spliceosome (GO:0000398), chromatin organization (GO:0006325), mitochondrion organization (GO:0007005), spermatogenesis (GO:0007283), single fertilization (GO:0007338), protein ubiquitination (GO:0016567), SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146), piRNA processing (GO:0034587), axoneme assembly (GO:0035082), protein catabolic process (GO:0030163), cilium organization (GO:0044782)
GO Molecular Function (3): ubiquitin-protein transferase activity (GO:0004842), ubiquitin-like ligase-substrate adaptor activity (GO:1990756), protein binding (GO:0005515)
GO Cellular Component (4): ubiquitin ligase complex (GO:0000151), nucleus (GO:0005634), cytoplasm (GO:0005737), SCF ubiquitin ligase complex (GO:0019005)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| organelle organization | 2 |
| RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 1 |
| mRNA processing | 1 |
| cellular component organization | 1 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| fertilization | 1 |
| protein modification by small protein conjugation | 1 |
| proteasome-mediated ubiquitin-dependent protein catabolic process | 1 |
| regulatory ncRNA processing | 1 |
| microtubule bundle formation | 1 |
| cellular component assembly | 1 |
| cilium assembly | 1 |
| macromolecule catabolic process | 1 |
| protein metabolic process | 1 |
| plasma membrane bounded cell projection organization | 1 |
| ubiquitin-like protein transferase activity | 1 |
| enzyme-substrate adaptor activity | 1 |
| binding | 1 |
| intracellular protein-containing complex | 1 |
| transferase complex | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| cullin-RING ubiquitin ligase complex | 1 |
Protein interactions and networks
STRING
490 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FBXO24 | RCC1 | P18754 | 675 |
| FBXO24 | NUDCD2 | Q8WVJ2 | 589 |
| FBXO24 | CUL1 | Q13616 | 582 |
| FBXO24 | SKP1 | P34991 | 580 |
| FBXO24 | FBXL12 | Q9NXK8 | 521 |
| FBXO24 | NUDCD3 | Q8IVD9 | 456 |
| FBXO24 | MAP3K6 | O95382 | 440 |
| FBXO24 | FBXO28 | Q9NVF7 | 440 |
| FBXO24 | DOT1L | Q8TEK3 | 410 |
| FBXO24 | CASKIN2 | Q8WXE0 | 407 |
| FBXO24 | PDRG1 | Q9NUG6 | 366 |
| FBXO24 | RPL17 | P18621 | 364 |
| FBXO24 | INSR | P06213 | 355 |
| FBXO24 | MRPL12 | P52815 | 351 |
| FBXO24 | TEX29 | Q8N6K0 | 348 |
| FBXO24 | CTNNA1 | P35221 | 348 |
IntAct
22 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NUDCD2 | FBXO24 | psi-mi:“MI:0915”(physical association) | 0.620 |
| HSP90AB1 | FBXO24 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FBXO24 | HSP90AB1 | psi-mi:“MI:0914”(association) | 0.560 |
| FBXO24 | PRMT6 | psi-mi:“MI:0915”(physical association) | 0.400 |
| Hacd3 | FBXO24 | psi-mi:“MI:0915”(physical association) | 0.400 |
| FBXO24 | HSP90AB1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| FBXO24 | psi-mi:“MI:0915”(physical association) | 0.400 | |
| FBXO24 | HSF2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| FBXO24 | NUDC | psi-mi:“MI:0915”(physical association) | 0.400 |
| FBXO24 | NUDCD3 | psi-mi:“MI:0915”(physical association) | 0.400 |
| FBXO24 | HSP90AA1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| FKBPL | FBXO24 | psi-mi:“MI:0915”(physical association) | 0.400 |
| STUB1 | FBXO24 | psi-mi:“MI:0915”(physical association) | 0.400 |
| CACYBP | FBXO24 | psi-mi:“MI:0915”(physical association) | 0.400 |
| FBXO24 | PTGES3 | psi-mi:“MI:0915”(physical association) | 0.400 |
| FBXO24 | AARSD1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| FBXO24 | PPP5C | psi-mi:“MI:0915”(physical association) | 0.400 |
| FBXO24 | psi-mi:“MI:0915”(physical association) | 0.400 | |
| FBXO24 | PSME3 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (24): FBXO24 (Biochemical Activity), NME1 (Affinity Capture-Western), SKP1 (Affinity Capture-Western), CUL1 (Affinity Capture-Western), NME1 (Reconstituted Complex), PRMT6 (Affinity Capture-Western), FBXO24 (Affinity Capture-Western), FBXO24 (Affinity Capture-RNA), FAM192A (Affinity Capture-MS), PSME3 (Affinity Capture-MS), NUDCD2 (Affinity Capture-MS), FBXO24 (Affinity Capture-MS), FBXO24 (Affinity Capture-MS), FBXO24 (Affinity Capture-Western), KDM1A (Affinity Capture-Western)
ESM2 similar proteins: A0A2R8Y7D0, A3KMV1, A6NDN8, B9EHT4, D3YWQ0, F1MAB7, O23702, O54788, O75426, O76075, P04413, P0C5J9, P49897, P55073, Q1LZC5, Q28969, Q2T9Z2, Q2VPJ9, Q39491, Q3MHJ7, Q3TGW2, Q4R327, Q57VU6, Q58CZ0, Q5BIR3, Q5I3B1, Q5R4R7, Q5R686, Q5SPX3, Q5XI74, Q6DN07, Q6NXT1, Q6P7W2, Q6QN11, Q6X4W1, Q7L9B9, Q7TPD7, Q80TL4, Q8K485, Q8TBC3
Diamond homologs: O75426, Q4R327, Q52KW8, Q8BK67, Q8IS20, Q9D417, Q9P258, Q0D2D2, Q15751, F1RD40, O75592, P0C5Y8, P52499, Q15034, Q54VW7, Q5BIW4, Q5GLZ8, Q6NRS1, Q6NYE2, Q6PAV2, Q7TPH6, Q920R0, Q947D2, Q96Q42, Q9CYF5, Q9UII4
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 15 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| protein folding | 6 | 44.3× | 3e-07 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
103 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 85 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1467 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:100585876:CTCA:C | donor_loss | 1.0000 |
| 7:100585879:A:AC | donor_gain | 1.0000 |
| 7:100585879:A:C | donor_loss | 1.0000 |
| 7:100585879:ACCAG:A | donor_gain | 1.0000 |
| 7:100585880:C:CC | donor_gain | 1.0000 |
| 7:100585880:CCAG:C | donor_gain | 1.0000 |
| 7:100585880:CCAGC:C | donor_gain | 1.0000 |
| 7:100591857:G:GT | donor_gain | 1.0000 |
| 7:100591899:GGAT:G | donor_gain | 1.0000 |
| 7:100591900:G:GT | donor_gain | 1.0000 |
| 7:100591900:GAT:G | donor_gain | 1.0000 |
| 7:100591902:TG:T | donor_loss | 1.0000 |
| 7:100591903:G:GG | donor_gain | 1.0000 |
| 7:100594381:A:AG | acceptor_gain | 1.0000 |
| 7:100594382:G:GG | acceptor_gain | 1.0000 |
| 7:100594382:GA:G | acceptor_gain | 1.0000 |
| 7:100594540:AGG:A | donor_loss | 1.0000 |
| 7:100594541:GG:G | donor_loss | 1.0000 |
| 7:100594542:G:GA | donor_loss | 1.0000 |
| 7:100594543:T:G | donor_loss | 1.0000 |
| 7:100600170:G:T | donor_gain | 1.0000 |
| 7:100585879:AC:A | donor_gain | 0.9900 |
| 7:100585880:CC:C | donor_gain | 0.9900 |
| 7:100585880:CCA:C | donor_gain | 0.9900 |
| 7:100585883:G:A | donor_gain | 0.9900 |
| 7:100590246:G:GT | donor_gain | 0.9900 |
| 7:100590335:G:GT | donor_gain | 0.9900 |
| 7:100591665:A:AG | acceptor_gain | 0.9900 |
| 7:100591665:AGA:A | acceptor_loss | 0.9900 |
| 7:100591666:G:GC | acceptor_gain | 0.9900 |
AlphaMissense
3763 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:100591793:A:T | D150V | 0.999 |
| 7:100592895:T:A | V224D | 0.999 |
| 7:100592930:T:C | F236L | 0.999 |
| 7:100592932:C:A | F236L | 0.999 |
| 7:100592932:C:G | F236L | 0.999 |
| 7:100595651:A:T | N384I | 0.999 |
| 7:100595652:C:A | N384K | 0.999 |
| 7:100595652:C:G | N384K | 0.999 |
| 7:100595660:G:A | G387E | 0.999 |
| 7:100595669:G:A | G390E | 0.999 |
| 7:100592828:T:G | Y202D | 0.998 |
| 7:100592832:T:A | V203D | 0.998 |
| 7:100592903:T:G | Y227D | 0.998 |
| 7:100592942:T:C | F240L | 0.998 |
| 7:100592944:C:A | F240L | 0.998 |
| 7:100592944:C:G | F240L | 0.998 |
| 7:100595617:G:T | D373Y | 0.998 |
| 7:100595618:A:T | D373V | 0.998 |
| 7:100595645:G:T | G382V | 0.998 |
| 7:100595659:G:T | G387W | 0.998 |
| 7:100595660:G:T | G387V | 0.998 |
| 7:100595668:G:A | G390R | 0.998 |
| 7:100595668:G:C | G390R | 0.998 |
| 7:100600125:G:A | G434D | 0.998 |
| 7:100600131:G:A | G436D | 0.998 |
| 7:100600152:T:C | L443P | 0.998 |
| 7:100591792:G:C | D150H | 0.997 |
| 7:100591792:G:T | D150Y | 0.997 |
| 7:100591808:T:A | L155H | 0.997 |
| 7:100592826:T:C | L201P | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000083112 (7:100587590 A>C,G), RS1000253922 (7:100590493 G>A), RS1000303269 (7:100590720 C>T), RS1000601810 (7:100597616 A>G), RS1000870684 (7:100584604 G>T), RS1000880483 (7:100592969 A>C,G), RS1000931548 (7:100598609 G>A), RS1001198639 (7:100599344 C>T), RS1001403486 (7:100585632 TAAAGAGAA>T), RS1001434217 (7:100591741 G>A,C), RS1001651244 (7:100599868 C>T), RS1002217176 (7:100598880 G>A), RS1002248734 (7:100584752 G>C), RS1002256134 (7:100593515 C>A), RS1002307073 (7:100593963 G>A,T)
Disease associations
OMIM: gene MIM:609097 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010702_48 | Subcortical volume (MOSTest) | 6.000000e-10 |
| GCST010703_289 | Brain morphology (MOSTest) | 6.000000e-15 |
| GCST90002397_306 | Mean spheric corpuscular volume | 1.000000e-14 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004346 | neuroimaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| propionaldehyde | decreases expression | 1 |
| bisphenol A | decreases expression | 1 |
| 2,4,5,2’,4’,5’-hexachlorobiphenyl | decreases expression | 1 |
| 3,4,5,3’,4’-pentachlorobiphenyl | decreases expression | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression | 1 |
| abrine | decreases expression | 1 |
| 2,2’,4,4’-tetrabromodiphenyl ether | decreases expression | 1 |
| bisphenol S | affects cotreatment, decreases methylation | 1 |
| Fulvestrant | decreases methylation, affects cotreatment | 1 |
| Acetaminophen | increases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Endosulfan | increases expression | 1 |
| Estradiol | decreases expression | 1 |
| Lipopolysaccharides | affects response to substance, increases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Triclosan | increases expression | 1 |
| Urethane | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Cyclosporine | decreases expression | 1 |
| Aflatoxin B1 | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.